Imagion Biosystems Limited advises that the 200,000 Performance Rights issued to Directors of the Company under the Company Long-term Incentive Plan on 14 June 2018, and approved by shareholders at the Company’s Annual General Meeting held on 31 May 2018, have passed the continuous employment vesting condition and have now vested. Accordingly, the Company has today issued 200,000 Fully Paid Ordinary Shares to the Directors as approved by shareholders at the Annual General Meeting held on 31 May 2018.
The Stock Network Interview – Opening US trial sites for MagSense® breast cancer imaging
October 17, 2026
Lel Smits from The Stock Network sat down with Imagion Biosystems’ Bob Proulx to discuss how MagSense® looks to improve upon today’s imaging, what the